Paediatric Clinical Trials Conference 2017

Strengthening strategies in paediatric investigation plans remains paramount and with the EMA 10 year review of paediatric regulation a call has been made for greater guidance with the goal of increasing the number of safe paediatric therapeutics on the market. Join us as we discuss current clinical trials, implementation and paediatric drug development in a series of interactive conference sessions, roundtables and workshops led by leading industry experts. KEYNOTE SPEAKERS INCLUDE: Bianca McDade, Director Regulatory Affairs, GSK Tom Willgoss, Senior Outcomes Research Scientist, Patient-Centred Outcomes Research, Roche Karl- Heinz Huemer, Scientifi c Committee Member and Expert, EMA Austria Hernando Patino, Paediatric Drug Development Lead, Johnson and Johnson Deborah Lee, VP Clinical Development, Insys Therapeutics Don't miss post-conference workshop: Paediatric drug development: Paediatric Investigation Plans (PIPs), challenges and strategies